Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Palantir Technologies Surges 2.4% Today - Is There Still Upside?

Shares of Palantir Technologies rose to $160.99 during today's afternoon trading session. Despite the 2.4% change, the Large-Cap Software company still trades 6.4% above its average analyst target price of $151.31. So there may be further downside for the Software stock. Palantir Technologies has target prices ranging from $45.0 to $200.0 per share, and its average rating is hold.

The stock has an average amount of shares sold short at 2.5%, and a short ratio of 0.94. The company's insiders own 3.62% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 57.1% of Palantir Technologies's shares being owned by this investor type.

Institutions Invested in Palantir Technologies

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 9% 205,717,666 $33,119,228,983
2025-06-30 Blackrock Inc. 8% 177,230,734 $28,533,015,061
2025-06-30 State Street Corporation 4% 94,481,128 $15,210,857,549
2025-06-30 Geode Capital Management, LLC 2% 49,704,870 $8,002,166,285
2025-06-30 Morgan Stanley 2% 32,948,594 $5,304,512,979
2025-06-30 NORGES BANK 1% 24,262,451 $3,906,099,490
2025-06-30 Invesco Ltd. 1% 20,585,256 $3,314,094,605
2025-06-30 Northern Trust Corporation 1% 20,319,224 $3,271,265,154
2025-06-30 FMR, LLC 1% 19,039,473 $3,065,233,425
2025-06-30 Goldman Sachs Group Inc 1% 17,887,465 $2,879,767,502

Besides an analyst consensus of little upside potential, other market factors point to there being mixed market sentiment on Palantir Technologies.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS